WASHINGTON, Nov. 19 -- National Institutes of Health has issued a notice called: Prospective Grant of an Exclusive Patent License: Methods for the Diagnosis and Prognosis of Cancer.
The notice was published in the Federal Register on Nov. 19 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.
Summary: The National Cancer Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATIONsection of this notice to BioncoDx, L...